It develops in fetuses of women with anti-Ro/SSA and anti-La/SSB autoantibodies who may have autoimmune diseases, such as Sjögren’s syndrome (SS) and systemic lupus erythematosus (SLE); however, it may not be associated with other diseases. This evidence concerns the gene TRIM21 and systemic lupus erythematosus.